Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Yan Hwang

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|February 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MMHoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2014
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective studyWai-Kay Seto, Thomas S Y Chan, Yu-Yan Hwang, et al.
The American Journal of Gastroenterology|December 8, 2016
Erratum: Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, DannyKa-Ho Wong, ThomasSau-Yan Chan, et al.
The American Journal of Gastroenterology|September 21, 2016
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, Danny Ka-Ho Wong, Thomas Sau-Yan Chan, et al.
Leukemia & Lymphoma|January 26, 2012
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study GroupSeok Jin Kim, Joon Ho Moon, Hawk Kim, et al.
Emerging Infectious Diseases|October 19, 2017
Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, ChinaVincent C C Cheng, Siddharth Sridhar, Shuk-Ching Wong, et al.
Cancer|March 27, 2018
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective studyHarinder Gill, Rita Yim, Harold K K Lee, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective studyWai-Kay Seto, Thomas Sau-Yan Chan, Yu-Yan Hwang, et al.
Therapeutic Advances in Hematology|April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gainHoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Annals of Hematology|April 12, 2022
Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacyYu-Yan Hwang, Thomas S Y Chan, Florence H Y Chan, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|February 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MMHoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2014
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective studyWai-Kay Seto, Thomas S Y Chan, Yu-Yan Hwang, et al.
The American Journal of Gastroenterology|December 8, 2016
Erratum: Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, DannyKa-Ho Wong, ThomasSau-Yan Chan, et al.
The American Journal of Gastroenterology|September 21, 2016
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, Danny Ka-Ho Wong, Thomas Sau-Yan Chan, et al.
Leukemia & Lymphoma|January 26, 2012
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study GroupSeok Jin Kim, Joon Ho Moon, Hawk Kim, et al.
Emerging Infectious Diseases|October 19, 2017
Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, ChinaVincent C C Cheng, Siddharth Sridhar, Shuk-Ching Wong, et al.
Cancer|March 27, 2018
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective studyHarinder Gill, Rita Yim, Harold K K Lee, et al.
Hepatology (Baltimore, Md.)|December 28, 2016
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective studyWai-Kay Seto, Thomas Sau-Yan Chan, Yu-Yan Hwang, et al.
Therapeutic Advances in Hematology|April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gainHoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Annals of Hematology|April 12, 2022
Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacyYu-Yan Hwang, Thomas S Y Chan, Florence H Y Chan, et al.
Pageof 6